"Monoclonal antibodies are laboratory-produced proteins that can bind to certain targets in the body, such as antigens on the surface of cancer cells. Monoclonal antibodies help diagnose and treat many diseases such as cancers. They may also be used alone or carry drugs, toxins, or radioactive substances directly to cancer cells. The possible side effects of monoclonal antibodies are fever, allergic reactions, flu-like symptoms, nausea, vomiting, diarrhea, skin rashes, and low blood pressure. "
Donanemab: For Early Alzheimer's Treatment
Donanemab is an Alzheimer's disease medication. This monoclonal antibody drug slows the progression of Alzheimer's disease when taken in the early stages.
Alemtuzumab: Powerful Treatment, Benefits, and Important Risks
Alemtuzumab is a monoclonal antibody. It signals the body's immune system to destroy the cancer cells. To know more, read the article below.
Monoclonal Antibodies: A Breakthrough in Treating Airway Conditions
Examining the role of monoclonal antibodies in treating airway diseases, emphasizing their precise targeting and potential to revolutionize treatment.
Eculizumab - A Wonder Drug for a Rare Blood Disorder
Eculizumab is recommended to reduce hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Read the article to learn more.
Ixekizumab - Indications, Pharmacology, Warnings, and Precautions
Ixekizumab is a biologically designed protein with therapeutic properties for tackling psoriatic arthritis.
Monoclonal Gammopathies of Undetermined Significance
Monoclonal gammopathies of undetermined significance are premalignant disorders that produce abnormal proteins. Read this article to know more about them.
Monoclonal Antibodies: Casirivimab and Imdevimab
Amidst the emerging third wave of COVID, researchers suggest using monoclonal antibodies-Casirimivab and Imdevimab in comorbid patients.
